{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bacterial+Resistance", "query": { "condition": "Bacterial Resistance" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 206, "total_pages": 21, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bacterial+Resistance&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-22T12:39:21.280Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03604705", "title": "An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Candidemia" ], "interventions": [ { "name": "APX001", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Basilea Pharmaceutica", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 21, "start_date": "2018-10-03", "completion_date": "2020-07-02", "has_results": true, "last_update_posted_date": "2025-09-16", "last_synced_at": "2026-07-22T12:39:21.280Z", "location_count": 9, "location_summary": "Birmingham, Alabama • Davis, California • Sacramento, California + 5 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Davis", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Augusta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03604705" }, { "nct_id": "NCT00619580", "title": "Ampicillin-sulbactam Resistant E.Coli at UPMC", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Positive E Coli Infections" ], "interventions": [], "intervention_types": [], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2008-02", "completion_date": "2014-12", "has_results": false, "last_update_posted_date": "2014-12-08", "last_synced_at": "2026-07-22T12:39:21.280Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00619580" }, { "nct_id": "NCT00100386", "title": "Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR*ICU) Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bacterial Diseases" ], "interventions": [ { "name": "Intensive Control Strategy", "type": "PROCEDURE" }, { "name": "Standard Control Strategy", "type": "BEHAVIORAL" } ], "intervention_types": [ "PROCEDURE", "BEHAVIORAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 30000, "start_date": "2005-03", "completion_date": "2006-08", "has_results": false, "last_update_posted_date": "2011-06-10", "last_synced_at": "2026-07-22T12:39:21.280Z", "location_count": 19, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Tucson, Arizona + 15 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00100386" }, { "nct_id": "NCT05303662", "title": "Prevalence of Multidrug Resistant Micro-organism Carriage in Patients Undergoing an ERCP in Four Different Countries", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Drug Resistance, Multiple, Bacterial", "Cholangiopancreatography, Endoscopic Retrograde" ], "interventions": [ { "name": "Multidrug-Resistant Organisms (MDRO) testing through rectal and oral/nasal swabs", "type": "DIAGNOSTIC_TEST" }, { "name": "MDRO-testing duodenal aspirate", "type": "DIAGNOSTIC_TEST" }, { "name": "Microbiome through rectal swab", "type": "DIAGNOSTIC_TEST" }, { "name": "Microbiome testing duodenal aspirate", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Marco J. Bruno", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1244, "start_date": "2022-01-31", "completion_date": "2024-12-30", "has_results": false, "last_update_posted_date": "2025-08-08", "last_synced_at": "2026-07-22T12:39:21.280Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05303662" }, { "nct_id": "NCT00000796", "title": "A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections", "Tuberculosis" ], "interventions": [ { "name": "Cycloserine", "type": "DRUG" }, { "name": "Ethionamide", "type": "DRUG" }, { "name": "Capreomycin sulfate", "type": "DRUG" }, { "name": "Aminosalicylic acid", "type": "DRUG" }, { "name": "Streptomycin sulfate", "type": "DRUG" }, { "name": "Ethambutol hydrochloride", "type": "DRUG" }, { "name": "Amikacin sulfate", "type": "DRUG" }, { "name": "Isoniazid", "type": "DRUG" }, { "name": "Pyrazinamide", "type": "DRUG" }, { "name": "Pyridoxine hydrochloride", "type": "DRUG" }, { "name": "Levofloxacin", "type": "DRUG" }, { "name": "Rifampin", "type": "DRUG" }, { "name": "Clofazimine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 525, "start_date": null, "completion_date": "1998-10", "has_results": false, "last_update_posted_date": "2021-11-03", "last_synced_at": "2026-07-22T12:39:21.280Z", "location_count": 21, "location_summary": "Chicago, Illinois • Detroit, Michigan • Brooklyn, New York + 2 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Brooklyn", "state": "New York" }, { "city": "Brooklyn", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000796" }, { "nct_id": "NCT00341913", "title": "Network on Antimicrobial Resistance in Staphylococcus Aureus", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Staphylococcus Aureus" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": null, "start_date": "2000-03-16", "completion_date": "2008-06-17", "has_results": false, "last_update_posted_date": "2017-07-02", "last_synced_at": "2026-07-22T12:39:21.280Z", "location_count": 1, "location_summary": "Herndon, Virginia", "locations": [ { "city": "Herndon", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00341913" }, { "nct_id": "NCT01904188", "title": "Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Sepsis", "Systemic Inflammatory Response Syndrome", "Infection Mixed", "Infection, Bacterial", "Infection, Fungal", "Infection, Coronavirus", "Antibiotic Resistance Genes", "Human Genome Analysis" ], "interventions": [ { "name": "Gene Z or other rapid diagnostic techniques developed in our lab (as of 2018 not using Gene Z - now using In-Dx along with other developed techniquesregularly)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Michigan State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2500, "start_date": "2015-06", "completion_date": "2032-07", "has_results": false, "last_update_posted_date": "2026-06-08", "last_synced_at": "2026-07-22T12:39:21.280Z", "location_count": 2, "location_summary": "Lansing, Michigan", "locations": [ { "city": "Lansing", "state": "Michigan" }, { "city": "Lansing", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01904188" }, { "nct_id": "NCT03349268", "title": "Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Healthcare Associated Infection", "Clostridium Difficile Infection", "Infection Due to Multidrug Resistant Bacteria" ], "interventions": [ { "name": "Pulsed xenon ultraviolet (PX-UV) Device", "type": "DEVICE" }, { "name": "Sham Device", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25732, "start_date": "2017-07-07", "completion_date": "2020-04-15", "has_results": true, "last_update_posted_date": "2022-03-14", "last_synced_at": "2026-07-22T12:39:21.280Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03349268" }, { "nct_id": "NCT03140423", "title": "Mupirocin-Iodophor ICU Decolonization Swap Out Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Staphylococcus Aureus" ], "interventions": [ { "name": "Arm 1. Routine Care (Mupirocin/CHG)", "type": "DRUG" }, { "name": "Arm 2. Iodophor/CHG Decolonization", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Harvard Pilgrim Health Care", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 353323, "start_date": "2017-05-01", "completion_date": "2023-11-06", "has_results": true, "last_update_posted_date": "2025-03-30", "last_synced_at": "2026-07-22T12:39:21.280Z", "location_count": 137, "location_summary": "Riverside, California • San Jose, California • Thousand Oaks, California + 103 more", "locations": [ { "city": "Riverside", "state": "California" }, { "city": "San Jose", "state": "California" }, { "city": "San Jose", "state": "California" }, { "city": "Thousand Oaks", "state": "California" }, { "city": "West Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03140423" }, { "nct_id": "NCT05488340", "title": "A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Urinary Tract Infections" ], "interventions": [ { "name": "LBP-EC01 0.1 x IV dose", "type": "DRUG" }, { "name": "LBP-EC01 0.01x IV Dose", "type": "DRUG" }, { "name": "LBP-EC01 IV Infusion Dose", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "LBP-EC01", "type": "DRUG" }, { "name": "TMP/SMX", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Locus Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "FEMALE", "summary": "18 Years to 75 Years · Female only" }, "enrollment_count": 318, "start_date": "2022-07-13", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-03-20", "last_synced_at": "2026-07-22T12:39:21.280Z", "location_count": 17, "location_summary": "Fresno, California • Lancaster, California • Los Angeles, California + 13 more", "locations": [ { "city": "Fresno", "state": "California" }, { "city": "Lancaster", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Montebello", "state": "California" }, { "city": "Murrieta", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05488340" } ] }